Home/Pipeline/Muhi Series

Muhi Series

Insect bites, skin inflammation, itching

Approved/CommercialMarketed

Key Facts

Indication
Insect bites, skin inflammation, itching
Phase
Approved/Commercial
Status
Marketed
Company

About KOBAYASHI Pharmaceutical

Kobayashi Pharmaceutical is a major Japanese player in the self-medication and consumer health market, with a history spanning over a century. The company has built a robust business model around developing, manufacturing, and marketing a wide array of OTC pharmaceuticals, quasi-drugs, functional foods, and household products. Its strategy focuses on brand power, channel strength, and continuous product innovation to address everyday health and wellness needs, with significant operations across Asia and a growing international presence.

View full company profile